Methicillin—resistant staphylococcus aureus or MRSA
Andrew studied chemistry at the University of Oxford before he went on to apply these skills to investigate how life works at a molecular level. During his PhD at the University of Cambridge, he focused on how nature makes the antibiotics we use to treat antibiotic-resistant infections including MRSA. In 2009, he moved to the MRC Laboratory of Molecular Biology as a Career Development Fellow; here he investigated how the machinery within cells interacts to enable basic processes including the replication of DNA. Then in 2013, Andrew moved to the Cambridge Institute where he built on these experiances to lead a team characterising the molecular interactions that drive cancer.
In 2018, Andrew was awarded a Turing Fellowship at the Alan Turing Institute to support the application of deep-learning strategies to model the biological systems he studies. These models will predict new therapies that bypass resistance and minimise side-effects in patients.
CRUK Cambridge Institute
Andrew leads a research team at Cancer Research UK's Cambridge Institute. His research programme brings together his experience of cutting-edge mass spectrometry, DNA and RNA sequencing techniques with computational biology to investigate novel opportunities to bypass theraputic resistance in cancer.
Nuclear receptors play a key role in the progression and treatment of several forms of cancer, including leukemia, breast and prostate cancer. For example, in 70% of all breast cancer cases, the Estrogen Receptor (ER) drives the growth and proliferation of the tumour and is a key target for the drug Tamoxifen. Unfortunately, in 10-40% of patients, resistance to these therapies occur. It is therefore urgent to find new ways to improve patient survival.
Andrew aims to achieve this goal by understanding the bigger picture of how resistance to these therapies occurs. Through the characterisation of the biological systems that nuclear receptors are part of, and how these systems regulate the progression of cancer, his work provides the networks of interactions that are the context needed to understand how resistance arises. This context will enable the future development of new therapies to bypass or prevent resistance. The technologies he has pioneered in meeting these goals have already been applied by other research groups around the world.
Onstage at the Bloomsbury Theatre
Andrew has worked on many science outreach and public engagement projects including founding and organising Skeptics in the Pub in Cambridge, which holds monthly talks by various speakers with the aim of highlighting the application of critical thinking and scientific method. Notable speakers include popular non-fiction author Simon Singh, statistician David Spiegelhalter and historian Christopher Andrew.
His public engagement work has been supported by several organisation including the MRC; and he was successful in his application for a Catalyst Award from UnLtd and the HEFCE for Social Entrepreneurship to help fund his work. His project received further funding from a Wellcome Trust People Award to produce a range of podcasts that support his events.
Andrew has been a guest on the The Naked Scientists Q&A radio show as Dr Andy, answering the public's questions on science. Futher to this, he produced and hosted this own radio show The Science of Fiction on CamFM that aired on Sunday evenings that covered the science behind movies, books and TV shows. In 2014 it became a live show at the Cambridge Science Centre as part of the Festival of Ideas with a follow-up show on Cambdrige TV in 2016. He has also been involved in current news having been interviewed by BBC Radio 5 Live's 5 Live Drive and BBC Cambridgeshire on topical science stories.
He has worked with the BBC on several shows as part of a British Science Assocation Media Fellowship, including Horizon and The One Show and written for The Guardian's 'Comment is Free' section along with BlueSci magazine. In 2013 he presented his first show for the BBC World Service called ''What if ... we could all become Cyborgs'.
Cancer Research UK Cambridge Institute
University of Cambridge
Li Ka Shing Centre
Tel: +44 (0) 1223 769 500
E-mail: Andrew.Holding at cruk.cam.ac.uk